Survey Results
Early findings from our survey-based observations are promising.
Among four stroke survivors who completed both baseline and post-program assessments, three showed measurable gains in overall recovery, with the largest improvements in hand dexterity, mood, mobility, and re-engagement with daily roles.
On average, participants’ hand-function scores rose by more than 12 points on the 0-100 Stroke Impact Scale, while emotion and mobility domains climbed by 10 and 9 points respectively—without any consistent decline in other areas.
These data reinforce the potential of carefully supported psychedelic microdosing to complement conventional rehabilitation and enhance quality of life after stroke.
Critical Disclaimer
The data below come from a very small, self-selected pilot group and should be viewed as preliminary and exploratory rather than conclusive evidence of efficacy. Outcomes were self-reported and uncontrolled for confounding factors such as spontaneous recovery, concurrent therapies, medication changes, or placebo effects; therefore causal links between psychedelic microdosing and functional gains cannot be established.
Psychedelic substances carry medical, psychological, and legal risks that vary by individual and jurisdiction; the information presented here is not medical advice nor an endorsement of any specific treatment. Always consult your physician or multidisciplinary care team before making changes to your rehabilitation plan, and ensure full compliance with all applicable laws, regulations, and professional guidelines.
Overall SIS Score: Baseline vs Post Protocol
Three of four individuals improved; none declined.
Overall change for each individual respondent as follows:
Respondent 1 : +10.7
Respondent 2: +0.3
Respondent 3: +3.4
Respondent 4: +5.5
Average Change in SIS Domains
Brief commentary on what we’re seeing:
Hand Function: Strongest signal – dexterity based items
Emotion: Marked mood lift
Participation: Better return to roles and recreation
Memory & Thinking: Mild cognitive easing
ADL/IADL: Essentially flat
Communication: Neutral on average (individual variation)
Strength: One respondent reported lower perceived strength; others static
Key Takeaways
Fine-motor & Emotional domains respond best to the current protocol; we may consider highlighting these goals for future cohorts.
Age & Recovery Paradigm – preliminary trend demonstrates <5 yrs post-stroke and <65 yrs of age achieved measurable improvement.
Strength lag may suggest adjunct physical therapy necessary alongside microdosing/intervention to translate neuroplastic benefits into perceived power.
Potential Safety/Tolerability – No domain-level deterioration aside from a single subjective strength dip – overall appears reasonable to explore further.